UCB - Operating Profit



UCB reported EUR1B in Operating Profit for its fiscal semester ending in December of 2024.


Operating Profit Change Date
Alcon AG USD 247M 221M Jun/2025
Almirall EUR 43.02M 8.82M Jun/2025
Amarin USD -16755000 35.77M Mar/2025
argenx SE USD 203.84M 64.9M Jun/2025
AstraZeneca USD 3.51B 166M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Galapagos EUR -57027000 101.68M Jun/2025
Genmab DKK 360M 172M Jun/2025
GlaxoSmithKline GBP 2.02B 193M Jun/2025
GRIFOLS EUR 349.54M 80.68M Jun/2025
Hikma Pharmaceutical USD 282M 45M Dec/2024
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.03B 24M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Orion EUR 104.6M 26.7M Jun/2025
Recordati EUR 149.95M 45.82M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
Sanofi EUR 1.71B 573M Jun/2025
UCB EUR 1B 678M Dec/2024
Unibail Rodamco EUR 462.7M 36.05M Dec/2024